This site is intended for healthcare professionals only
LoginRegister
Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP TrialSun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide
Eli Lilly Jaypirca met its primary endpoint in head-to-head Phase 3 study versus ImbruvicaCDSCO Ends Emergency-Use Authorization of Baricitinib for COVID-19 Treatment
Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancerMerck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev...
CDSCO Alert: 64 Drug Batches Including Metformin, Paracetamol Declared Not of Standard Quality in NovemberCDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of...
Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDAZydus bags Health Canada approval for Mesalamine suppositories for active ulcerative proctitis
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer Lynkuet gets USFDA nod for treatment of moderate to severe vasomotor symptoms due to menopause
MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI to Upgrade Drug, Food Testing LabsTelangana: Medical shop seized, licence cancelled for illegal sale of Schedule H1 drugs
Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in ChileAurobindo Pharma arm Eugia Pharma B.V incorporates wholly owned subsidiary in Chile
Lupin secures SBTi validation for emission reduction targetsLupin unveils authorized generic version of Ravicti in US
Delhi pharma firm owner caught in drug trafficking case in JammuManipur: 91 bottles of psychotropic cough syrup seized, 1 arrested
GSK Exdensur wins USFDA approval for severe asthmaGSK Blenrep approved by USFDA for relapsed/refractory multiple myeloma
Lilly to buy Adverum BiotechnologiesEli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal
X